Literature DB >> 11918562

Syngeneic stem cell transplant for spent-phase polycythaemia vera: eradication of myelofibrosis and restoration of normal haematopoiesis.

Shambavi Richard1, Luis Isola, Eileen Scigliano, Harvinder Singh, Vesna Najfeld, Harriet Gilbert, Rona S Weinberg, Steven Fruchtman.   

Abstract

We report a patient with spent-phase polycythaemia vera (S-PV) and massive splenomegaly who failed to engraft after a syngeneic granulocyte colony-stimulating factor-primed peripheral blood stem cell transplant (SCT), but later engrafted after splenectomy. Bone marrow (BM) showed resolution of myelofibrosis (MF) and absent endogenous erythroid colonies. This case demonstrated that (1) normal haematopoiesis can be restored after syngeneic SCT despite extensive MF, and (2) fibrosis can regress following a total body irradiation-containing regimen and syngeneic SCT. As a graft-versus-BM stroma effect is non-existent in syngeneic transplants, there may be a role for autologous SCT to obliterate MF in S-PV.

Entities:  

Mesh:

Year:  2002        PMID: 11918562     DOI: 10.1046/j.1365-2141.2002.03387.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

Authors:  Karen K Ballen; Ann E Woolfrey; Xiaochun Zhu; Kwang Woo Ahn; Baldeep Wirk; Mukta Arora; Biju George; Bipin N Savani; Brian Bolwell; David L Porter; Ed Copelan; Gregory Hale; Harry C Schouten; Ian Lewis; Jean Yves Cahn; Joerg Halter; Jorge Cortes; Matt E Kalaycio; Joseph Antin; Mahmoud D Aljurf; Matthew H Carabasi; Mehdi Hamadani; Philip McCarthy; Steven Pavletic; Vikas Gupta; H Joachim Deeg; Richard T Maziarz; Mary M Horowitz; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-24       Impact factor: 5.742

Review 2.  Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia.

Authors:  William J Hogan; Mark R Litzow; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 3.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.